Technique identifies chemotherapy-resistant cells within acute myeloid leukemia tumors

September 6, 2016, JCI Journals

Although chemotherapy can sometimes cure acute myeloid leukemia and other hematologic cancers, many patients experience relapses when their tumors become resistant to available chemotherapies. This resistance may be caused by the survival and proliferation of chemotherapy-resistant cells that were already present in the tumor prior to treatment. Studying the characteristics of these cells could help researchers understand and develop better approaches to target chemotherapy-resistant cancers.

This month in the JCI, Anthony Letai and colleagues at the Dana-Farber Cancer Institute developed an assay to determine how variability within a population of can predict responses to chemotherapy in acute myeloid leukemia patients.

The assay, which was performed on , measured each cell's sensitivity to mitochondrial apoptosis, a type of cell death that is induced by many existing chemotherapies.

They determined that the least sensitive cells in a tumor could predict how successfully a patient responded to chemotherapy. Developing the ability to identify chemotherapy-resistant tumors and tumor cells prior to treatment may lead to clinical insights that improve therapeutic outcomes in and other cancers.

Explore further: Study provides new clues to leukemia resurgence after chemotherapy

More information: Patrick D. Bhola et al, Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI82908

Related Stories

Study provides new clues to leukemia resurgence after chemotherapy

June 2, 2016
For the first time, researchers have discovered that some leukemia cells harvest energy resources from normal cells during chemotherapy, helping the cancer cells not only to survive, but actually thrive, after treatment.

Immune cells help reverse chemotherapy resistance in ovarian cancer

May 20, 2016
Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles:

Tumor microenvironment acts as a mechanism of resistance to chemotherapy

September 6, 2016
Researchers at Bellvitge Biomedical Research Institute (IDIBELL) have published a study in Oncotarget that highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the ...

Identification of a novel tyrosine kinase inhibitor for acute myeloid leukemia

March 17, 2016
Acute myeloid leukemia (AML) is a cancer of myeloid stem cells that develops in both adult and pediatric populations. Mutations that cause hyperactivation of the FMS-like tyrosine kinase 3 (FLT3) are commonly found in AML, ...

As leukemia evolves, stem cells hold keys to newer therapies

August 30, 2016
A recent study by University of Rochester Medical Center researchers proves why leukemia is so difficult to treat and suggests that the current approach to drug development should be adjusted to target a broader range of ...

Innate immune landscape in glioblastoma patient tumors

February 25, 2016
Glioblastoma is an extremely aggressive brain tumor with limited treatment options. Recent progress in using immunotherapy-based treatment options in other tumor types has spurred interest in developing approaches that might ...

Recommended for you

Scientists discover how breast cancer hibernates: study

May 22, 2018
Scientists have identified the mechanism that allows breast cancer cells to lie dormant in other parts of the body only to reemerge years later with lethal force, according to a study published Tuesday.

Researcher: Big data, networks identify cell signaling pathways in lung cancer

May 22, 2018
A team of scientists led by University of Montana cell biologist Mark Grimes has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

Resetting the epigenetic balance for cancer therapy

May 22, 2018
Though mutations in a gene called MLL3 are common across many types of cancers, their relationship to the development of the disease has been unclear. Now, a Northwestern Medicine study has identified an epigenetic imbalance ...

Downward-facing mouse: Stretching reduces tumor growth in mouse model of breast cancer

May 22, 2018
Many cancer patients seek out gentle, movement-based stretching techniques such as yoga, tai chi and qigong, but does stretching have an effect on cancer? While many animal studies have attempted to quantify the effects of ...

Compound in citrus oil could reduce dry mouth in head, neck cancer patients

May 21, 2018
A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine.

Ice cream funds research showing new strategy against thyroid cancer

May 21, 2018
Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis. And standard treatment for the condition includes 7 weeks of radiation, often along with chemotherapy.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.